Regulus Therapeutics

RGLSNASDAQ
$1.78
-0.24-11.85%
At Close: -
$1.78
-0.0050-0.28%
After Hours: 5:42 PM EDT
15 minutes delayed

Regulus Therapeutics (NASDAQ:RGLS) Stock Quotes, Forecast and News Summary

Regulus Therapeutics Stock (NASDAQ: RGLS) stock price, news, charts, stock research, profile.

Open$2.00
Close$1.79
Volume / Avg.8.11M / 697.24K
Day Range1.66 - 2.00
52 Wk Range1.08 - 3.79
Market Cap$116.53M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
34
Short Interest
6.94%
Days to Cover9.63
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
1
1
Mar
0
0
0
0
May
0
0
0
0
Jun
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.5
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Regulus Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
RGLS
GALT

FAQ

Q

How do I buy Regulus Therapeutics (RGLS) stock?

A

You can purchase shares of Regulus Therapeutics (NASDAQ:RGLS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Regulus Therapeutics (RGLS) competitors?

Q

What is the target price for Regulus Therapeutics (RGLS) stock?

A

There is no analysis for Regulus Therapeutics.

Q

What is the forecast for Regulus Therapeutics (RGLS) stock?

A

Regulus Therapeutics has a consensus price target of $9.50.

Q

Current stock price for Regulus Therapeutics (RGLS)?

A

The stock price for Regulus Therapeutics (NASDAQ: RGLS) is $1.78 last updated June 28, 2024 at 5:42 PM EDT.

Q

Does Regulus Therapeutics (RGLS) pay a dividend?

A

There are no upcoming dividends for Regulus Therapeutics.

Q

When is Regulus Therapeutics (NASDAQ:RGLS) reporting earnings?

A

Regulus Therapeutics’s Q2 earnings are confirmed for Tuesday, August 6, 2024.

Q

Is Regulus Therapeutics (RGLS) going to split?

A

There is no upcoming split for Regulus Therapeutics.

Q

What sector and industry does Regulus Therapeutics (RGLS) operate in?

A

Regulus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch